Emerging as the healthcare landscape, retatrutide represents a significant development in weight therapy space. This innovative dual stimulator targeting both GLP-1 and GIP receptors has shown impressive efficacy in research investigations, suggesting a greater ability to promote weight decrease and tackle associated metabolic concerns. While yet u